SOURCE-LINKED INTELLIGENCE

From fragments to high affinity binders interfacing integrated structural biology, medicinal chemistry and artificial intelligence

CORDIS · observation · Publication date unknown

From fragments to high affinity binders interfacing integrated structural biology, medicinal chemistry and artificial intelligence Fragment-Screen will develop innovative instrumentation, workflows and experimental and computational methodologies for fragment-based drug discovery (FBDD) enabling access to early phase structure-based drug discovery for all biological targets and for scientists both in industry and academia. The established workflows will use structural biology insights and associated data to feed artificial intelligence (AI) methodology to guide medicinal chemistry in drug development. Fragment-Screen brings together scientists from four ESFRI Landmark research infrastructures (RIs): ESRF (the European synchrotron) and the distributed RIs EU-OPENSCREEN ERIC (medicinal chemistry), ELIXIR (data resources for life science) under the coordination of Instruct-ERIC (integrated structural biology) and seven industry partners in scientific instrumentation and computational and AI sect

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

8265079.64

unit

EUR